These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9136506)

  • 1. Case study: risperidone-induced hepatotoxicity in pediatric patients.
    Kumra S; Herion D; Jacobsen LK; Briguglia C; Grothe D
    J Am Acad Child Adolesc Psychiatry; 1997 May; 36(5):701-5. PubMed ID: 9136506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver enzyme abnormalities during antipsychotic treatment: a case report of risperidone-associated hepatotoxicity.
    López-Torres E; Süveges A; Peñas-LLedó EM; Doña A; Dorado P; LLerena A; Berecz R
    Drug Metabol Drug Interact; 2014; 29(2):123-6. PubMed ID: 24598833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone-induced hepatotoxicity?
    Geller WK; Zuiderwijk PB
    J Am Acad Child Adolesc Psychiatry; 1998 Mar; 37(3):246-7. PubMed ID: 9519624
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute cholestatic hepatitis probably associated with risperidone.
    Llinares Tello F; Hernández Prats C; Bosacoma Ros N; Pérez Martínez E; Climent Grana E; Navarro Polo JN; Ordovás Baines JP
    Int J Psychiatry Med; 2005; 35(2):199-205. PubMed ID: 16240976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six months of treatment with risperidone may be associated with nonsignificant abnormalities of liver function tests in children and adolescents: a longitudinal, observational study from Turkey.
    Erdogan A; Karaman MG; Ozdemir E; Yurteri N; Tufan AE; Kurcer MA
    J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):407-13. PubMed ID: 20973711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Disorder of liver functions in a schizophrenic patient after long-term risperidone treatment--case report].
    Radzik J; Grotthus B; Leszek J
    Psychiatr Pol; 2005; 39(2):309-13. PubMed ID: 15881625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone-induced cholestatic hepatitis.
    Krebs S; Dormann H; Muth-Selbach U; Hahn EG; Brune K; Schneider HT
    Eur J Gastroenterol Hepatol; 2001 Jan; 13(1):67-9. PubMed ID: 11204814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone-induced hepatotoxicity.
    Benazzi F
    Pharmacopsychiatry; 1998 Nov; 31(6):241. PubMed ID: 9930641
    [No Abstract]   [Full Text] [Related]  

  • 9. Is liver function monitoring warranted during risperidone treatment?
    Landau J; Martin A
    J Am Acad Child Adolesc Psychiatry; 1998 Oct; 37(10):1007-8. PubMed ID: 9785708
    [No Abstract]   [Full Text] [Related]  

  • 10. Risperidone-associated steatohepatitis and excessive weight-gain.
    Holtmann M; Kopf D; Mayer M; Bechtinger E; Schmidt MH
    Pharmacopsychiatry; 2003 Sep; 36(5):206-7. PubMed ID: 14571356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid onset of risperidone-induced hepatotoxicity.
    Phillips EJ; Liu BA; Knowles SR
    Ann Pharmacother; 1998; 32(7-8):843. PubMed ID: 9681106
    [No Abstract]   [Full Text] [Related]  

  • 12. Risperidone-associated hepatotoxicity.
    Fuller MA; Simon MR; Freedman L
    J Clin Psychopharmacol; 1996 Feb; 16(1):84-5. PubMed ID: 8834428
    [No Abstract]   [Full Text] [Related]  

  • 13. Risperidone-induced hepatotoxicity in children and adolescents? A chart review study.
    Szigethy E; Wiznitzer M; Branicky LA; Maxwell K; Findling RL
    J Child Adolesc Psychopharmacol; 1999; 9(2):93-8. PubMed ID: 10461819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone- and paliperidone-induced hepatotoxicity: Case report and review of literature.
    Khorassani F; Sousonis F; Lopez LV
    Am J Health Syst Pharm; 2020 Sep; 77(19):1578-1584. PubMed ID: 32699878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone-induced hepatotoxicity in a patient addicted to synthetic cannabinoid.
    Saglam O; Bahsi R; Akkoca Y; Filik L
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):360-1. PubMed ID: 26825144
    [No Abstract]   [Full Text] [Related]  

  • 16. Risperidone rechallenge for marked liver function test abnormalities in an autistic child.
    Copur M; Erdogan A
    Recent Pat Endocr Metab Immune Drug Discov; 2011 Sep; 5(3):237-9. PubMed ID: 21913889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.
    Schooler N; Rabinowitz J; Davidson M; Emsley R; Harvey PD; Kopala L; McGorry PD; Van Hove I; Eerdekens M; Swyzen W; De Smedt G;
    Am J Psychiatry; 2005 May; 162(5):947-53. PubMed ID: 15863797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone in the treatment of children and adolescents with schizophrenia: a retrospective study.
    Grcevich SJ; Findling RL; Rowane WA; Friedman L; Schulz SC
    J Child Adolesc Psychopharmacol; 1996; 6(4):251-7. PubMed ID: 9231318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability and safety profile of risperidone in a sample of children and adolescents.
    Margari L; Matera E; Craig F; Petruzzelli MG; Palmieri VO; Pastore A; Margari F
    Int Clin Psychopharmacol; 2013 Jul; 28(4):177-83. PubMed ID: 23689836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risperidone and liver function tests in children and adolescents: a short-term prospective study.
    Erdogan A; Atasoy N; Akkurt H; Ozturk D; Karaahmet E; Yalug I; Yalug K; Ankarali H; Balcioglu I
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):849-57. PubMed ID: 18258348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.